Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-15

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA has approved a supplemental application for acetazolamide submitted by Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diamox (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)